PAR 4.55% 23.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-88

  1. 882 Posts.
    lightbulb Created with Sketch. 265
    Still too many unknowns for me. I come out thinking the risk is greater than ever.

    US BP has one eye on open re funding.

    Understands it’s near impossible to raise in current market and keep value.

    Reliance on CCP bodies to get this over the line?

    TGA a slowburn

    Absolute dosing mess due to a rat

    Overly waffly from PR bordering on unprofessional at times. Dropped the ball on one word “we have tried to….” Maybe looking for “improve”?

    Thank the team once and press on.

    CLearly strategy chops and changes on any new piece of info. No “laser focus”

    Won’t be selling based on the drug, equally won’t be buying based on team’s ability to execute.

    These were my notes on the fly.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
0.010(4.55%)
Mkt cap ! $80.45M
Open High Low Value Volume
23.0¢ 23.0¢ 21.0¢ $185.1K 837.7K

Buyers (Bids)

No. Vol. Price($)
1 100000 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 10000 1
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.